RecruitingNCT06330584
Nasal midazolam or placebo for acute anxiety in palliative care
About this title
Read the official source — NCT06330584Medication studyAges 18+Switzerland
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Basel and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 20, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 36
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Switzerland
- Age range
- Over 18 Years
- Official registry ID
- NCT06330584
- Official title
Show the full official title
Administration of Intranasal Midazolam for Anxiety in Palliative Care - a Double-blind, Randomized, Placebo-controlled Multicenter Exploratory Pilot Study With a Nested Pharmacokinetic Analysis
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Basel · Bern · Zurich
Questions about this study
Who is behind this study?
The study sponsor is Insel Gruppe AG, University Hospital Bern, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Placebo Nasal Spray 0 mg/spray, Midazolam Nasal Spray 0.45 mg/spray and Midazolam Nasal Spray 0.9 mg/spray.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
